• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多参数磁共振成像在前列腺癌主动监测中的应用。

Use of multiparametric magnetic resonance imaging in prostate cancer active surveillance.

机构信息

Department of Urology, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.

出版信息

BJU Int. 2019 Nov;124(5):730-737. doi: 10.1111/bju.14705. Epub 2019 Mar 13.

DOI:10.1111/bju.14705
PMID:30740876
Abstract

OBJECTIVES

To review the role of multiparametric magnetic resonance imaging (mpMRI) for active surveillance (AS) of prostate cancer.

MATERIALS AND METHODS

We performed a comprehensive search of Medline and Embase databases for relevant articles in the English language. Search terms included 'prostate cancer', 'active surveillance' or 'monitoring', 'expectant management', and 'MRI'. We also reviewed practice guidelines from recognized international associations or societies involved in prostate cancer care. Articles were selected by both authors for relevance to the subject matter.

RESULTS

The ability of mpMRI to visualize primarily high-grade tumours within the prostate may improve risk stratification for men considering AS for prostate cancer. Multiple mostly single-institution studies have found that the addition of mpMRI and a targeted biopsy strategy can improve AS patient selection over standard TRUS biopsy alone. The high negative predictive value of mpMRI may allow men to avoid early repeat biopsy and may offer the possibility to tailor biopsy strategies. The presence of a radiographically positive lesion on mpMRI at baseline is predictive of higher likelihood of radiographic progression over time while on AS.

CONCLUSIONS

MRI has shown promise in both patient selection and monitoring for men who undergo AS for prostate cancer. There are multiple barriers to the widespread use of mpMRI for AS including quality, cost and access to care.

摘要

目的

综述多参数磁共振成像(mpMRI)在前列腺癌主动监测(AS)中的作用。

材料与方法

我们在 Medline 和 Embase 数据库中用英文检索相关文献,检索词包括“前列腺癌”“主动监测”或“监测”“期待治疗”和“MRI”。我们还复习了参与前列腺癌诊治的国际知名协会或学会的实践指南。两位作者均根据与主题的相关性来选择文章。

结果

mpMRI 能够显示前列腺内主要的高级别肿瘤,这可能有助于对考虑接受前列腺癌 AS 的男性进行风险分层。多项主要为单中心的研究发现,mpMRI 联合靶向活检策略可改善 AS 患者的选择,优于单纯标准经直肠超声(TRUS)活检。mpMRI 的高阴性预测值可使男性避免早期重复活检,并可能提供定制活检策略的可能性。基线时 mpMRI 上存在影像学阳性病变预示着在 AS 期间随着时间推移发生影像学进展的可能性更高。

结论

MRI 在接受前列腺癌 AS 的男性的患者选择和监测方面均显示出良好的效果。mpMRI 广泛应用于 AS 存在多个障碍,包括质量、成本和获得医疗服务的机会。

相似文献

1
Use of multiparametric magnetic resonance imaging in prostate cancer active surveillance.多参数磁共振成像在前列腺癌主动监测中的应用。
BJU Int. 2019 Nov;124(5):730-737. doi: 10.1111/bju.14705. Epub 2019 Mar 13.
2
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?多参数磁共振成像第二意见可能减少不必要的前列腺活检数量:是否需要改进放射科医生的培训计划?
Clin Genitourin Cancer. 2019 Apr;17(2):88-96. doi: 10.1016/j.clgc.2018.10.006. Epub 2018 Oct 23.
3
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.在未经前列腺活检的患者中进行前列腺癌风险评估:多参数磁共振成像-经直肠超声(TRUS)融合活检和系统 TRUS 活检中的鹿特丹前列腺癌风险计算器。
Eur Urol Oncol. 2018 Jun;1(2):109-117. doi: 10.1016/j.euo.2018.02.010. Epub 2018 May 15.
4
Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.磁共振成像引导下前列腺活检与监测的不确定病变:文献综述。
Eur Urol Focus. 2019 Sep;5(5):799-806. doi: 10.1016/j.euf.2018.02.012. Epub 2018 Mar 7.
5
Magnetic resonance imaging in prostate cancer detection and management: a systematic review.磁共振成像在前列腺癌检测与管理中的应用:一项系统综述。
Minerva Urol Nefrol. 2017 Dec;69(6):567-578. doi: 10.23736/S0393-2249.17.02819-3. Epub 2017 May 8.
6
Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.多参数磁共振成像作为高度疑似前列腺癌男性的一线工具的临床实用性。
Eur Urol Oncol. 2018 Aug;1(3):208-214. doi: 10.1016/j.euo.2018.03.008. Epub 2018 May 15.
7
Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.3特斯拉多参数磁共振成像及靶向活检在考虑进行主动监测的患者中改善风险分层的价值
BJU Int. 2017 Apr;119(4):535-542. doi: 10.1111/bju.13624. Epub 2016 Sep 3.
8
What to expect from a non-suspicious prostate MRI? A review.可疑前列腺 MRI 之外的情况如何?一篇综述。
Prog Urol. 2020 Dec;30(16):986-999. doi: 10.1016/j.purol.2020.09.012. Epub 2020 Sep 29.
9
The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer.前列腺癌活检前多参数磁共振成像的诊断准确性。
BJU Int. 2019 Jan;123(1):82-90. doi: 10.1111/bju.14420. Epub 2018 Jul 26.
10
Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance.多参数磁共振成像在主动监测中对 1 级前列腺癌男性进行风险分层的作用。
BJU Int. 2020 Jun;125(6):861-866. doi: 10.1111/bju.15033. Epub 2020 Mar 2.

引用本文的文献

1
Evaluating the Role of Ultrasound in Prostate Cancer trial - phase 1: Early experience of micro-ultrasound in the United Kingdom.评估超声在前列腺癌试验中的作用——1期:英国微超声的早期经验。
Ultrasound. 2024 Nov;32(4):244-252. doi: 10.1177/1742271X231226302. Epub 2024 Feb 14.
2
MR Molecular Imaging of Extradomain-B Fibronectin for Assessing Progression and Therapy Resistance of Prostate Cancer.用于评估前列腺癌进展和治疗抗性的胞外区域B纤连蛋白的磁共振分子成像
Chem Biomed Imaging. 2024 Jun 11;2(8):560-568. doi: 10.1021/cbmi.4c00002. eCollection 2024 Aug 26.
3
Treatment of intermediate-risk prostate cancer with active surveillance in the routine care-Long-term outcomes of a prospective noninterventional study (HAROW).
常规护理中对中危前列腺癌进行主动监测的治疗——一项前瞻性非干预性研究(HAROW)的长期结果
Curr Urol. 2024 Jun;18(2):115-121. doi: 10.1097/CU9.0000000000000203. Epub 2024 Jun 21.
4
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial.基因组检测对低危前列腺癌中泌尿科医生治疗偏好的影响:一项随机试验。
Cancer Med. 2023 Oct;12(19):19690-19700. doi: 10.1002/cam4.6615. Epub 2023 Oct 3.
5
Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool.前列腺癌患者主动监测中简化版与多参数前列腺MRI的比较:作为决策工具的准确性和临床实用性对比
Diagnostics (Basel). 2023 Feb 4;13(4):578. doi: 10.3390/diagnostics13040578.
6
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation.泌尿外科医生准备好解读多参数磁共振成像结果了吗?一项前瞻性多中心评估。
Diagnostics (Basel). 2022 Nov 1;12(11):2656. doi: 10.3390/diagnostics12112656.
7
The role of diagnostic ultrasound imaging for patients with known prostate cancer within an active surveillance pathway: A systematic review.诊断性超声成像在前列腺癌主动监测路径中对已知前列腺癌患者的作用:一项系统评价。
Ultrasound. 2022 Feb;30(1):4-17. doi: 10.1177/1742271X21995212. Epub 2021 Apr 15.
8
Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach.多参数 MRI 在前列腺癌主动监测中的应用:综述与实用方法。
Korean J Radiol. 2021 Jul;22(7):1087-1099. doi: 10.3348/kjr.2020.1224. Epub 2021 Apr 1.
9
Modern imaging and image-guided treatments of the prostate gland: MR and ablation for cancer and prostatic artery embolization for benign prostatic hyperplasia.前列腺的现代成像与图像引导治疗:用于癌症的磁共振成像和消融以及用于良性前列腺增生的前列腺动脉栓塞术。
BJR Open. 2019 Aug 14;1(1):20190019. doi: 10.1259/bjro.20190019. eCollection 2019.
10
Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study.在社区环境下对局限性前列腺癌进行主动监测的长期结果:一项前瞻性非干预性研究的结果。
World J Urol. 2021 Jul;39(7):2515-2523. doi: 10.1007/s00345-020-03471-x. Epub 2020 Sep 30.